CELU
$1.22-0.05 (-3.94%)
Market ClosedAs of Mar 20, 8:00 PM UTC
Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases.
Recent News
Poolbeg Pharma adds CAR-T therapy expert to scientific advisory board
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the AIM-listed clinical-stage biopharmaceutical company, has appointed Dr Adrian Kilcoyne to its Scientific Advisory Board, bringing more than 20 years of oncology and immunology drug development experience to the company. Kilcoyne is...
Celularity Second Quarter 2025 Earnings: US$1.02 loss per share (vs US$0.30 loss in 2Q 2024)
Celularity ( NASDAQ:CELU ) Second Quarter 2025 Results Key Financial Results Revenue: US$5.74m (down 53% from 2Q 2024...
Retail investors among Celularity Inc.'s (NASDAQ:CELU) largest shareholders, saw gain in holdings value after stock jumped 11% last week
NasdaqCM:CELU 1 Year Share Price vs Fair Value Explore Celularity's Fair Values from the Community and select yours Key...